Search Results

Vanderbilt-Ingram Cancer Center Ray Blind, PhD, has been named associate director for Diversity, Equity and Inclusion at Vanderbilt-Ingram Cancer Center. He is a nationally recognized investigator in the understanding of the structure, function, and signaling of nuclear lipids.

The Tisch Cancer Institute at Mount Sinai Miriam Merad, MD, PhD, has been appointed dean for Translational Research and Therapeutic Innovation of the Icahn School of Medicine at Mount Sinai. She will focus on cultivating a culture of mechanistic clinical trials throughout the campus and forging stronger partnerships with the pharmaceutical and biotech sectors. 

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Novel therapeutic approaches are needed for children with diffuse midline glioma (DMG) and other recurrent high-grade central nervous system (CNS) tumors, aggressive brain cancers with poor prognoses. A type of immunotherapy using T cells modified with chimeric antigen receptors (CAR T) has demonstrated efficacy in other cancers, but use in DMG and other CNS tumors has been limited.

University of Florida Health Cancer Center In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma.

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Researchers at The Ohio State University Comprehensive Cancer Center –James Cancer Hospital and Solove Research Institute say results of a Phase II, multi-center clinical trial revealed that a new type of cell therapy is a promising potential treatment option for patients with stage 4 lung cancer who were previously treated but later developed resistance to other therapies.

Northwell Health Cancer Institute All four Northwell Health hospitals with cardiothoracic surgery programs earned three-star overall quality ratings, the highest rating given, in several surgical categories analyzed by the Society of Thoracic Surgeons.

UCLA Jonsson Comprehensive Cancer Center Tanya Stoyanova, PhD, was awarded an Exploration-Hypothesis Development Award from the Department of Defense to develop new approaches to detect and treat neuroendocrine prostate cancer.

University of New Mexico Comprehensive Cancer Center The UNM Comprehensive Cancer Center has named Eliseo F. Castillo, PhD, as associate director of Diversity, Equity and Inclusion. He has been deeply engaged in several mentoring and outreach programs at the center.

UC Davis Comprehensive Cancer Center UC Davis Comprehensive Cancer Center Interim Physician-in-Chief David Tom Cooke, MD, is now associate director of the center’s Office of Inclusion, Diversity, Equity and Accessibility (IDEAL). Dr. Cooke (at right, in photo) will lead the newly appointed IDEAL team that includes assistant directors Miquell Olivia Miller, MD, and Luis Godoy, MD.

UCLA Jonsson Comprehensive Cancer Center UCLA Health Jonsson Comprehensive Cancer Center investigators have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas.

Stanford Cancer Institute Scientists at Stanford and the Children’s Hospital of Philadelphia have identified a protein, FOXO1, that improves the survival and function of CAR T cells, which may lead to more effective CAR T-cell therapies and could potentially expand its use in difficult-to-treat cancers.

Fox Chase Cancer Center, Temple Health Camille Ragin, PhD, MPH, associate director for Diversity, Equity, and Inclusion at Fox Chase Cancer Center, received the American Association for Cancer Research’s (AACR) Minorities in Cancer Research Jane Cooke Wright Lectureship. She delivered the lecture at the AACR Annual Meeting 2024 in San Diego.

University of Virginia Cancer Center Evan A. Scott, PhD, an expert in the use of nanotechnology to understand and fight disease, will head up the University of Virginia’s Institute for Nanoscale Scientific and Technological Advanced Research, or nanoSTAR, as UVA enters a new era in nanotechnology research with the launch of the Paul and Diane Manning Institute of Biotechnology.

The University of Arizona Cancer Center Researchers at the University of Arizona Cancer Center have been working for more than two years with international researchers to uncover the compound called DYR747 that targets vulnerabilities in colorectal cancer. They synthesized and tested more than 300 derivatives of their compound to optimize its accuracy, strength, and tumor-shrinking effectiveness.

The Stanford Cancer Institute (SCI) is one of an elite number of National Cancer Institute-Designated Comprehensive Cancer Centers in the country, and is a prominent, dynamic, growing and complex Institute within the Stanford University School of Medicine. The SCI actively works to build synergies and collaborations among faculty with cancer-relevant expertise from four Schools and over 30 departments across Stanford University. We seek a Clinical Research Coordinator 2 to help us enact our mis…

Save the date for the 17th Annual AACI CRI Meeting, June 23-25, 2025, at Loews Chicago O'Hare Hotel in Rosemont, IL.

Save the date for the 2025 AACI/CCAF Annual Meeting, October 19-21, at Salamander Washington DC.

At 12:00 pm eastern time on Tuesday, June 18, in advance of the Juneteenth holiday, join Association of Cancer Care Centers (ACCC) President Nadine J. Barrett, PhD, MA, MS, FACCC, and AACI President Robert A. Winn, MD, in an empowering discussion about a shared organizational goal to advance equitable cancer care.

On Thursday, May 16, AACI co-hosted the 2024 Hill Day with the American Association for Cancer Research (AACR). One hundred participants, representing 27 states, presented a unified voice supporting stable funding increases for the National Institutes of Health and the National Cancer Institute.

Patricia LoRusso, DO, PhD, will present a keynote at 8:30 am central time on Tuesday, June 25, during the 16th Annual AACI Clinical Research Innovation (CRI) Meeting in Rosemont, IL. Dr. LoRusso is an oncologist and associate director of innovative medicine at the Yale School of Medicine. Her keynote, "The Making of a Clinical Researcher: A Personal Journey," will detail the inspiring story of her path to clinical research.

The 16th Annual AACI CRI Meeting will be held June 24-26 at Loews Chicago O'Hare Hotel in Rosemont, IL.

The American Cancer Society, the National Cancer Institute, and Cancer Research UK are holding a new annual conference on prevention research, June 25-27, in Boston.

In advance of the Juneteenth holiday, a celebration of progress in equity, join Association of Cancer Care Centers (ACCC) President Dr. Nadine J. Barrett and Association of American Cancer Institutes (AACI) President Dr. Robert A. Winn in an empowering discussion about a shared organizational goal to advance equitable cancer care. What will it take for the cancer community to effect real change? Hear about the science behind outreach engagement and learn how you can begin to contribute to the c…

Robert L. Ferris, MD, PhD, a head and neck surgical oncologist, leading expert in cancer immunotherapy, and cancer center chief executive, has been named the executive director of UNC Lineberger Comprehensive Cancer Center and UNC system chief of oncology services, effective October 1. Dr. Ferris comes to UNC from the University of Pittsburgh Medical Center (UPMC), where he was the director of the Hillman Cancer Center.

Lawrence H. Einhorn, MD, a distinguished professor in the Indiana University School of Medicine Department of Medicine and a pioneer in testicular cancer treatment, will present a keynote at 1:45 pm central time on Sunday, October 20, during the 2024 AACI/CCAF Annual Meeting in Chicago.

The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) invite nominations and applications to lead the Fred Hutch Breast Cancer Program. The position will be dual appointed with a primary faculty appointment in the Clinical Research Division at Fred Hutch and a secondary appointment in the UW Department of Medicine, Division of Hematology and Oncology. The position will report to the Senior Vice President (SVP) of the Clinical Research Division at Fred Hutch and t…

The 2025 AACI Catchment Area Data Excellence (CADEx) Conference is scheduled for January 29-31, in San Diego. The three-day event will convene cancer center catchment area data experts with others who support cancer centers through data analysis and community engagement. Attendees will share best practices in data collection, handling, dissemination, and utilization, while exploring policies and methodologies to advance cancer center catchment area analytics.

Roswell Park Comprehensive Cancer Center Roswell Park Comprehensive Cancer Center has earned its most highly rated grant from the National Cancer Institute (NCI). The NCI renewed Roswell Park’s status as a Comprehensive Cancer Center, awarding it the highest possible "Exceptional" rating as it renewed a grant Roswell Park has successfully competed for since 1972. Candace S. Johnson, PhD, is president and CEO of the cancer center.

Winship Cancer Institute of Emory University In a recent study led by Suresh Ramalingam, MD, executive director of Winship Cancer Institute of Emory University, a new drug—Osimertinib—has shown remarkable promise in treating patients with a specific type of advanced lung cancer.  

Findings from a 2023 survey of cancer center clinical trials offices were published July 1 in JCO Oncology Practice. The lead authors of "North American Cancer Center Clinical Research Capacity and Benchmarking in the Post-Pandemic Era" are Thomas J. George, MD, FACP, FASCO, University of Florida Health Cancer Center; Margaret Kasner, MD, MSCE, Sidney Kimmel Comprehensive Cancer Center at Jefferson; Angela Fritsche, MPA, Mayo Clinic Comprehensive Cancer Center; and Carrie B. Lee, MD, UNC Linebe…

USC Norris Comprehensive Cancer Center A clinical trial will test the feasibility of treating non-small cell lung cancer with immunotherapy provided at home. The study will examine if a new formulation of atezolizumab can be safely and effectively administered subcutaneously by a nurse at a patient’s home, along with telemedicine appointments and remote monitoring through wearable trackers.

Northwell Health Cancer Institute Northwell Health and the START Center for Cancer Research (START), a global network of fully dedicated, community-based, early-phase oncology clinical trial sites, have announced partnership plans. A new START early-phase clinical trial site is to be established at the Zuckerberg Cancer Center, part of Northwell Health’s Cancer Institute.

The Department of Medicine of the University of Maryland School of Medicine and the Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCC) located in Baltimore, MD are seeking additional faculty to join our expanding programs.  Our programs emphasize the multimodality care of oncology patients and clinical and translational research. The essential functions of these positions include inpatient/outpatient consultations and longitudinal patient care, teaching and mentoring of Hematolo…

Join our cancer enterprise at Cedars-Sinai Cancer during a transformational period of growth and help us achieve our goal of becoming a top tier nationally recognized Cancer Center. Ranked by US News & World Report as the #14 Best Hospital in Cancer in 2023-2024. We are seeking a Breast Medical Oncologist who will focus on breast cancer and the development of translational research and clinical trials for the treatment of these diseases. The selected candidate will have programmatic, clini…

Join Cedars-Sinai Cancer during a transformational period of growth and be a part of our mission to solve unmet needs in cancer by studying populations we are uniquely positioned to address, through serving the diverse population of Los Angeles, and then translating discoveries to global impacts. We are seeking a Medical Oncologist who will focus on the development of translational research and clinical trials for medical oncology as a key leader in the Experimental Therapeutics Program. The s…

The Sidney Kimmel Comprehensive Cancer Center (SKCCC) and the Department of Medical Oncology at TJU in Philadelphia, Pennsylvania is excited to announce a new faculty position who will serve as the Associate Director (AD) of Population Science in SKCCC and the Chief of the Division of Population Science in the Department of Medical Oncology. The AD will be a senior executive leader who will report to the director of SKCCC and the Chair of the Department. The candidate should be an accomplished …

AACI convened its 16th annual Clinical Research Innovation (CRI) meeting June 24-26, in Rosemont, IL. With a focus on clinical trial office operations, the signature event drew over 600 attendees with 153 abstracts submitted for presentation. Photo credit: Randy Belice

UCSF Helen Diller Family Comprehensive Cancer Center UC San Francisco researchers have received $12.45 million from the National Cancer Institute (NCI) to lead the first long-term study of cancer among Asian Americans, a highly diverse yet understudied group. A 2016 review of NCI grants found almost no studies on the causes of cancer among Asian Americans.

The University of Chicago Medicine Comprehensive Cancer Center Pancreatic cancer researchers from the Midwest convened in May for the first-ever PancMidwest Pancreatic Cancer Research Symposium. The event gathered 130 multidisciplinary researchers and physicians at the the University of Chicago.

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute While most rates of cancer continue to decrease, oncologists express concern that rates of uterine cancer (also known as endometrial cancer) continue to rise, and this trend disproportionately affects Black women.

University of Florida Health Cancer Center Marking the first anniversary of its National Cancer Institute (NCI) designation, the University of Florida Health Cancer Center has highlighted 10 key achievements of the past year.

On June 18, Association of Cancer Care Centers (ACCC) President Dr. Nadine J. Barrett and AACI President Dr. Robert A. Winn engaged in a lively and empowering discussion about the two organizations' shared goal to advance equitable cancer care. Pictured: Drs. Nadine J. Barrett and Robert A. Winn at the 2024 ASCO Annual Meeting

UAMS Winthrop P. Rockefeller Cancer Institute Gwendolyn Bryant-Smith, MD, director of the Breast Center at the University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute, has received the prestigious designation of Fellow of the American College of Radiology.

The University of Kansas Cancer Center The Kansas Institute for Precision Medicine will continue its mission to improve health care by training physicians and scientists in precision medicine and supporting their research, thanks to a five-year, $11.4 million grant renewal from the National Institute of General Medical Sciences, part of the National Institutes of Health.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers from the Johns Hopkins Kimmel Cancer Center and other institutions have developed and validated a liquid biopsy that may help identify lung cancer earlier.

Sidney Kimmel Comprehensive Cancer Center at Jefferson A research team led by Renato V. Iozzo, MD, PhD (honoris causa), an investigator with the Sidney Kimmel Comprehensive Cancer Center at Jefferson, has identified that decorin, a proteoglycan expressed by stromal elements in tumors, has antilymphangiogenic properties.

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center celebrated a gift of $10.8 million from the Estate of Concetta "Chet" Greenberg, an ardent champion of cancer research during her life. This gift is the culmination of many years of support, bringing Greenberg’s total giving to nearly $20 million for pancreatic cancer research at Fox Chase.

Stony Brook Cancer Center Breast cancer research at the Stony Brook Cancer Center is taking a leap forward thanks to support from the Carol M. Baldwin Breast Cancer Research Fund. The fund has established a new $5.5 million endowment that will be used in perpetuity for breast cancer research.

University of New Mexico Comprehensive Cancer Center The UNM Comprehensive Cancer Center has launched the Southwest Transformative Educational Advancement and Mentoring Network (STEAM), a program that bridges researchers and mentors across four research institutions in the Southwest. Dolores Guest, PhD, RD, serves as the UNM principal investigator for the STEAM Network.

The Division of Oncology in the Department of Medicine at Stanford University seeks medical oncologists as Assistant, Associate, or full Professor in the University Medical Line (UML). We are seeking at least two board-certified or eligible medical oncologists to join the Head and Neck Oncology Program as clinician scientists. We are particularly interested in early-career professionals whose aspirations align with our team-based approach and who would benefit from our exceptional mentorship op…

The Houston Methodist Dr. Mary and Ron Neal Cancer Center (HMNCC) is seeking applicants for a senior leadership and faculty position in its Cancer Prevention and Control (CPC) research program. The HMNCC has a distinguished research and clinical enterprise impacting the lives of patients within its catchment area. Under the leadership of Jenny C. Chang, MD, the Cancer Center is on the trajectory of scientific growth while actively pursuing National Cancer Institute (NCI) designation. The Cancer…

Winship Cancer Institute of Emory University President Biden has appointed Edjah K. Nduom, MD, to the National Cancer Advisory Board. Dr. Nduom leads the Brain Tumors Disease Group at Winship Cancer Institute of Emory University.

UK Markey Cancer Center New research reveals concerning declines in cervical cancer screening rates among women in the U.S. during the COVID-19 pandemic, especially in rural areas. The study, led by UK Markey Cancer Center, analyzed nationally representative survey data from the National Cancer Institute to examine Pap test screening rates before and during the pandemic.

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the breadth of possibilities for treating cancer.

University of New Mexico Comprehensive Cancer Center The UNM Comprehensive Cancer Center now offers new Chimeric Antigen Receptor (CAR) T-cell therapy. Shashank Cingam, MD, recently joined the UNM Comprehensive Cancer Center’s Bone Marrow Transplant and Cellular Therapy Team and has helped launch the CAR T program.

The Medical University of South Carolina (MUSC) and NCI-designated Hollings Cancer Center (HCC) seek a nationally recognized and dynamic leader to serve as its Associate Director (AD) of Population Sciences. The successful candidate will be appointed a tenure-track Associate or Full Professor, depending on experience and qualifications. Candidates from backgrounds underrepresented in medicine and/or science are strongly encouraged to apply. Serving on the senior leadership team of HCC, the suc…

The Hollings Cancer Center (HCC) at the Medical University of South Carolina (MUSC) is the only National Cancer Institute (NCI)-designated Cancer Center in the State of South Carolina, serving 5.2M residents. As the only NCI-designated cancer center in South Carolina, HCC is part of an elite network of 72 cancer centers across the country recognized for our dedication to delivering cutting-edge treatments to patients and conducting innovative research to serve the unique needs of our state. HCC…

The Tisch Cancer Institute at Mount Sinai Kenneth Rosenzweig, MD, a radiation oncologist and American Board of Radiology (ABR) volunteer, has been named to the organization’s board of trustees. Dr. Rosenzweig will start at the end of the fall board meeting in late September.

The University of Chicago Medicine Comprehensive Cancer Center The surge in popularity of AI tools such as ChatGPT is forcing the science community to reckon with its place in scientific literature. A new study evaluated text from over 15,000 published abstracts from the American Society for Clinical Oncology Annual Meeting from 2021 to 2023. It found that there were approximately twice as many abstracts containing AI content in 2023 as compared to 2021 and 2022.

Stanford Cancer Institute A large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR T-cell therapy is low, despite a U.S. Food and Drug Administration warning.

Roswell Park Comprehensive Cancer Center A research effort led by Roswell Park Comprehensive Cancer Center sheds light on the biology and mechanisms behind castration-resistant prostate cancer. The team’s findings, reflecting six years of collaborative research, offer a new understanding of castration resistance and prostate cancer biology that could point the way to new treatment strategies.

UCSF Helen Diller Family Comprehensive Cancer Center UCSF faculty and clinicians working to take on the challenge of glioblastoma multiforme (GBM) treated their first patient with a promising chimeric antigen receptor (CAR) T-cell therapy that was fully conceived, designed, optimized and manufactured at UCSF. GBM is the most common and aggressive primary brain tumor with a tremendously poor prognosis of 14-month median survival.

Siteman Cancer Center The Leukemia & Lymphoma Society has awarded Washington University researchers at Siteman Cancer Center a $5 million grant to support trials in cell-based immunotherapies and cancer vaccines.  

Stanford Cancer Institute Howard Chang, MD, PhD, has been awarded the 2024 Lurie Prize in Biomedical Sciences by the Foundation for the National Institutes of Health. He was honored for his research into the role of long noncoding RNAs in health and disease.

UCLA Jonsson Comprehensive Cancer Center Dennis Slamon, MD, PhD, an oncologist and scientist whose groundbreaking research has transformed the treatment of breast cancer, has been awarded the 2024 Szent-Györgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research.

University of Michigan Rogel Cancer Center Changing how often a popular cancer therapy is delivered would reduce greenhouse gas emissions and improve environmental impact without decreasing cancer survival, according to an analysis from researchers at the University of Michigan Health Rogel Cancer Center.

Huntsman Cancer Institute at the University of Utah Researchers at the University of Utah have designed new digital tools that prompt doctors to consider lung cancer screening for high-risk patients and provide personalized guidance on screening. Since their implementation, the digital tools have sparked doctor-patient conversations and quadrupled the amount of lung cancer screens for high-risk patients.

UC Davis Comprehensive Cancer Center Scientists at UC Davis Comprehensive Cancer and the UC Davis Department of Radiology have discovered a novel way to image the unique blood supply of the lungs. Their findings suggest it could help determine if lung cancer treatment is working.

Siteman Cancer Center A study by Washington University researchers at Siteman Cancer Center suggests a new strategy of using gut microbes to help unlock immunotherapy’s untapped cancer-fighting potential.

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute researchers have found a potentially effective drug-combination approach to treating certain patients with non-small cell lung cancer.

UCLA Jonsson Comprehensive Cancer Center UCLA scientists have identified a protein that plays a critical role in regulating human blood stem cell self-renewal by helping them sense and interpret signals from their environment. The study brings researchers one step closer to developing methods to expand blood stem cells in a lab dish.

Siteman Cancer Center Eric Duncavage, MD, a research member of Siteman Cancer Center, has been named director of the newly created Division of Genomic and Molecular Pathology at Washington University School of Medicine in St. Louis.

City of Hope Comprehensive Cancer Center Preliminary results from a first in-human Phase I trial using a chimeric antigen receptor (CAR) T cell therapy developed by researchers from City of Hope® in patients with advanced prostate cancer showed promise, with minimal side effects.

USC Norris Comprehensive Cancer Center A new study suggests that a bone marrow transplant from a haploidentical, or half-identical, relative may greatly increase patients’ odds of success, in addition to being easier to find. The study may open life-saving opportunities for Hispanic patients, who are one-third less likely to find a fully matched donor from the national registry than white patients.

UK Markey Cancer Center Researchers at the University of Kentucky College of Nursing, DanceBlue Kentucky Children’s Hospital Hematology/Oncology Clinic, and UK Markey Cancer Center found that receiving financial and legal navigation services improves levels of financial toxicity and quality of life for patients and caregivers.

UAMS Winthrop P. Rockefeller Cancer Institute Researchers at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences have been awarded five new grants from the National Cancer Institute (NCI) in 2024, totaling $4.6 million.

University of Michigan Rogel Cancer Center A new study shows that a process called NETosis, in which neutrophils eject their DNA to create webs, may contribute to the development of cytokine release syndrome, a potentially life-threatening hyper-activation of the immune system.

Cedars-Sinai Cancer Cedars-Sinai has once again earned national recognition as an LGBTQ+ Healthcare Equality Leader. It is one of 384 U.S. health care facilities to receive this designation in the Human Rights Campaign Foundation’s Healthcare Equality Index.

GW Cancer Center Sonal Paul, MD, has joined the GW Cancer Center and the GW Medical Faculty Associates as a hematologist-oncologist specializing in gastrointestinal cancers.

The Tisch Cancer Institute at Mount Sinai A new report details the first evaluation of innate and adaptive immune response in bone marrow to a novel immunomodulatory molecule—Iberdomide—as part of a Phase I/II study.

The University of Kansas Cancer Center When prostate-specific antigen levels begin to rise again prostate cancer surgery, it often indicates a higher risk of the cancer spreading to other parts of the body. About half of men diagnosed with local prostate cancer will get metastatic cancer during their lifetime. Now, a pioneering clinical trial suggests that a novel treatment approach may improve outcomes.

The University of California, Irvine School of Medicine (UCI School of Medicine), in partnership with Korn Ferry, invites nominations and expressions of interest for the position of Chair, Department of Radiation Oncology. Rich in history and tradition and dedicated to advancing medical knowledge and clinical practice through scholarly research, education, and high-quality clinical care, UCI School of Medicine shines on the world stage as an enterprising champion of innovation and discovery. H…

Siteman Cancer Center Sana D. Karam, MD, PhD, will lead radiation oncology at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, beginning October 1. The role is part of her appointment as the James S. McDonnell Professor of Radiation Oncology and head of the Department of Radiation Oncology at WashU.

Save the date for the 17th Annual AACI CRI Meeting, June 23-25, 2025, at Loews Chicago O'Hare Hotel in Rosemont, IL.

The University of Vermont Cancer Center is seeking an outstanding candidate to fill a Postdoctoral Associate position focused on breast cancer epidemiology and data sciences. This position is under the supervision of Dr. Brian Sprague, PhD, who is Professor in the UVM Larner College of Medicine and co-Leader of the Cancer Population Sciences program within the Cancer Center. Dr. Sprague directs the Vermont Breast Cancer Surveillance System (VBCSS), a registry-based study that collects data on w…

Last month, AACI participated in a congressional briefing on cancer drug parity, hosted by the International Myeloma Foundation (IMF)-led Coalition to Improve Access to Cancer Care (CIACC). AACI leadership and staff also visited Washington as a sponsor of the Black in Cancer Conference and the 15th Annual Congressional Women's Softball Game.